Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Oxycodone	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Altered	B-Delirium
mental	B-Delirium
status	B-Delirium
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
F	O
with	O
CAD,	O
PVD	O
s/p	O
AKA	O
in	O
___,	O
chronic	O
C.	O
diff	O
infection,	O
CREST,	O
RA	O
on	O
prednisone	O
presented	O
to	O
the	O
ED	O
with	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
She	O
was	O
on	O
her	O
way	O
to	O
her	O
out-patient	O
post	O
op	O
appointment	O
in	O
an	O
ambulance	O
from	O
rehab	O
when	O
she	O
became	O
acutely	O
deliriuous,	B-Delirium
diaphoretic,	O
and	O
anxious	O
and	O
she	O
was	O
brought	O
here	O
to	O
the	O
ED.	O
Rehab	O
records	O
show	O
fever	O
to	O
101.2	O
at	O
12am	O
today.	O
She	O
was	O
recantly	O
discharged	O
from	O
the	O
medical	O
service	O
on	O
___	O
after	O
presenting	O
with	O
drainage	O
from	O
her	O
surgical	O
stump	O
with	O
a	O
leukocytosis.	O
During	O
that	O
admission,	O
she	O
was	O
continued	O
on	O
po	O
vancomycin	O
though	O
at	O
a	O
decreased	O
dose.	O
This	O
course	O
was	O
set	O
to	O
complete	O
on	O
___.	O
No	O
source	O
of	O
her	O
infection	O
was	O
noted	O
and	O
she	O
was	O
not	O
treated	O
with	O
antibiotics.	O
Of	O
note,	O
the	O
CXR	O
at	O
that	O
admission	O
was	O
noted	O
to	O
have	O
a	O
small	O
L	O
pleural	O
effusion.	O
In	O
the	O
ED,	O
initial	O
VS	O
not	O
noted	O
on	O
ED	O
dashboard.	O
CXR	O
showed	O
a	O
new	O
L	O
sided	O
oval	O
opacity	O
compared	O
to	O
CXR	O
on	O
___.	O
CT	O
chest	O
was	O
done	O
which	O
showed	O
a	O
new	O
left	O
sided	O
locuated	O
effusion.	O
The	O
ovoid	O
opacity	O
was	O
noted	O
to	O
be	O
pleural	O
fluid	O
tracking	O
into	O
the	O
fissure.	O
Her	O
labs	O
were	O
notable	O
for	O
a	O
leukocytosis	O
to	O
16	O
with	O
a	O
1%	O
bandemia.	O
UA	O
was	O
dirty.	O
She	O
received	O
a	O
dose	O
of	O
vancomycin	O
and	O
zosyn	O
for	O
UTI.	B-Urinary_tract_infection
She	O
dropped	O
her	O
pressures	O
to	O
the	O
80's	O
and	O
received	O
2L	O
IVF	O
bolus	O
with	O
recovery	O
of	O
her	O
pressures	O
to	O
the	O
low	O
100's.	O
Her	O
VS	O
prior	O
to	O
transfer:	O
97.4,	O
80,	O
103/69,	O
14,	O
98%.	O
On	O
arrival	O
to	O
the	O
floor,	O
the	O
patient	O
reports	O
she's	O
not	O
sure	O
why	O
she's	O
here.	O
SHe	O
reports	O
wheezing	O
-	O
she	O
normally	O
has	O
this	O
only	O
in	O
the	O
mornings	O
but	O
it	O
has	O
been	O
occuring	O
all	O
day	O
today.	O
It	O
is	O
not	O
worsened	O
or	O
improved	O
by	O
any	O
specific	O
position	O
or	O
maneuver.	O
She	O
denies	O
cough	O
or	O
sputum	O
production.	O
She	O
reports	O
fever	O
and	O
chills	O
at	O
rehab	O
but	O
is	O
unable	O
to	O
tell	O
me	O
how	O
long	O
that	O
had	O
been	O
going	O
on.	O
She	O
denies	O
abdominal	O
pain,	O
loose	O
stools	O
or	O
increased	O
stooling.	O
She	O
reports	O
feeling	O
nauseous	O
for	O
the	O
last	O
24	O
hours,	O
but	O
denies	O
vomiting.	O
Review	O
of	O
sytems:	O
(+)	O
Per	O
HPI	O
(-)	O
Denies	O
recent	O
weight	B-Weight_loss
loss	B-Weight_loss
or	O
gain.	O
Denies	O
headache,	O
sinus	O
tenderness,	O
rhinorrhea	O
or	O
congestion.	O
Denied	O
cough,	O
shortness	O
of	O
breath.	O
Denied	O
chest	O
pain	O
or	O
tightness,	O
palpitations.	O
Denied	O
vomiting,	O
diarrhea,	O
constipation	B-Constipation
or	O
abdominal	O
pain.	O
No	O
recent	O
change	O
in	O
bowel	O
or	O
bladder	O
habits.	O
No	O
dysuria.	O
Denied	O
arthralgias	O
or	O
myalgias.	O
Past	O
Medical	O
History:	O
Per	O
recent	O
OMR	O
discharge	O
note,	O
confirmed	O
with	O
patient	O
CAD	O
s/p	O
RCA	O
stent	O
in	O
___	O
(normal	O
LV	O
function	O
on	O
___	O
echocardiogram)	O
Peripheral	O
vascular	O
disease	O
s/p	O
bilateral	O
AKA	O
due	O
to	O
non-healing	O
wounds	O
with	O
MRSA	O
involvement	O
Clostridium	O
difficile	O
colitis	O
-	O
stopped	O
po	O
vancomycin	O
on	O
___	O
per	O
rehab	O
records	O
Hypertension	O
Essential	O
thrombocytosis	O
Rheumatoid	O
arthritis	O
on	O
prednisone	O
5mg	O
qd(Dx	O
at	O
age	O
___	O
Scleroderma	O
-	O
CREST	O
(Dx	O
___	O
yrs	O
ago,	O
no	O
pulmonary	O
complaints,	O
skin	O
and	O
GI	O
complaints)	O
Hypothyroidism	O
GERD	O
Anxiety	O
Chronic	O
Diarrhea	O
h/o	O
CVA	O
s/p	O
L5-S1	O
laminectomy	O
c/b	O
infected	O
epidural	O
abscess	O
(___)	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
to	O
current	O
presentation.	O
Physical	O
Exam:	O
Physical	O
Exam:	O
Vitals:	O
T:	O
97	O
BP:100/60	O
P:74	O
R:20	O
O2:99%	O
4Lnc	O
General:	O
Alert,	O
oriented	B-Unspecified_cognitive_impairment
to	O
self	O
and	O
year.	O
Not	O
to	O
location.	O
In	O
no	O
acute	O
distress	O
HEENT:	O
Sclera	O
anicteric,	O
markedly	O
dry	O
mucous	O
membrances	O
with	O
fissures	O
on	O
tongue	O
and	O
cracked	O
lips.	O
Oropharynx	O
clear	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
appreciated	O
Lungs:	O
Audible	O
expiratory	O
wheeze	O
without	O
ascultation.	O
Trace	O
crackles	O
at	O
R	O
base,	O
other	O
wise	O
clear	O
with	O
no	O
wheeze.	O
Left	O
with	O
nearly	O
absent	O
breath	O
sounds	O
at	O
the	O
left	O
base	O
with	O
crackles	O
to	O
mid	O
lung	O
field.	O
No	O
egophany.	O
Dull	O
to	O
percussion	O
at	O
L	O
base.	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
appreciated	O
Abdomen:	O
hyperactive	O
bowel	O
sounds,	O
soft,	O
non-tender,	O
non-distended,	O
no	O
rebound	O
tenderness	O
or	O
guarding	O
GU:	O
foley	O
in	O
place	O
draining	O
concentrated-appearing	O
urine	O
Ext:	O
bilateral	O
AKA.	O
L	O
side	O
with	O
surigcal	O
incision	O
C/D/I,	O
no	O
drainage.	O
R	O
side	O
with	O
surgical	O
incision	O
with	O
surgical	O
staples	O
in	O
place	O
and	O
overlaying	O
scabs	O
and	O
serosanguinous	O
drainage.	O
Contracted	O
hands	O
bilaterally.	O
Neuro:	O
CNs2-12	O
intact,	O
motor	O
function	O
grossly	O
normal	O
EXAM	O
ON	O
DISCHARGE:	O
Tm	O
99.1	O
Tc	O
99.0	O
BP	O
130s-140s/60s-70s	O
HR	O
___	O
RR	O
20	O
SpO2	O
92-98%	O
RA	O
Gen	O
anxious	O
but	O
in	O
no	O
acute	O
distress	O
Lungs	O
CTA	O
anteriorly	O
Cor	O
RRR	O
with	O
nl	O
S1	O
S2,	O
occ	O
irreg	O
irreg	O
Abd	O
soft	O
NTND	O
Ext	O
Left	O
stump	O
incision	O
is	O
well	O
healed,	O
right	O
stump	O
incision	O
has	O
crusting	O
of	O
blood	O
as	O
well	O
as	O
mild	O
surrounding	O
erythema	O
and	O
tenderness	O
along	O
incision.	O
Pertinent	O
Results:	O
LABS:	O
ON	O
ADMISSION:	O
-	O
URINE:	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-30	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-5.5	O
LEUK-TR	O
URINE	O
RBC-14*	O
WBC-8*	O
BACTERIA-FEW	O
YEAST-FEW	O
EPI-0	O
-	O
LACTATE-2.5*	O
-	O
CHEM	O
7:	O
GLUCOSE-121*	O
UREA	O
N-26*	O
CREAT-0.6	O
SODIUM-130*	O
POTASSIUM-5.5*	O
CHLORIDE-94*	O
TOTAL	O
CO2-22	O
ANION	O
GAP-20	O
-	O
CK(CPK)-43	O
-	O
cTropnT-0.04*	O
-	O
CBC:	O
WBC-16.9*#	O
RBC-4.78	O
HGB-11.9*	O
HCT-39.9	O
MCV-84	O
MCH-25.0*	O
MCHC-29.8*	O
RDW-26.2*	O
PLT	O
COUNT-349	O
-	O
DIFF:	O
NEUTS-78*	O
BANDS-1	O
LYMPHS-13*	O
MONOS-5	O
EOS-1	O
BASOS-1	O
ATYPS-1*	O
___	O
MYELOS-0	O
NUC	O
RBCS-1*	O
-	O
COAGS	O
___	O
PTT-25.2	O
___	O
-	O
ESR	O
(___)	O
40	O
mm/hr	O
-	O
CRP	O
(___)	O
145.8	O
mg/L	O
LABS	O
ON	O
DISCHARGE:	O
___	O
05:43AM	O
BLOOD	O
WBC-10.0	O
RBC-4.11*	O
Hgb-10.5*	O
Hct-35.6*	O
MCV-87	O
MCH-25.6*	O
MCHC-29.6*	O
RDW-24.7*	O
Plt	O
___	O
___	O
07:30AM	O
BLOOD	O
WBC-11.1*	O
RBC-4.03*	O
Hgb-10.1*	O
Hct-34.5*	O
MCV-86	O
MCH-25.1*	O
MCHC-29.4*	O
RDW-25.1*	O
Plt	O
___	O
___	O
07:30AM	O
BLOOD	O
___	O
PTT-25.9	O
___	O
___	O
05:43AM	O
BLOOD	O
Glucose-69*	O
UreaN-9	O
Creat-0.4	O
Na-146*	O
K-4.6	O
Cl-107	O
HCO3-29	O
AnGap-15	O
___	O
07:30AM	O
BLOOD	O
Glucose-98	O
UreaN-11	O
Creat-0.4	O
Na-143	O
K-4.5	O
Cl-107	O
HCO3-26	O
AnGap-15	O
___	O
05:43AM	O
BLOOD	O
Calcium-8.1*	O
Mg-2.0	O
IMAGING:	O
CXR	O
___	O
(Final	O
read)	O
1)	O
Increasing	O
size	O
of	O
left	O
pleural	O
effusion	O
which	O
is	O
now	O
moderate	O
in	O
extent.	O
2)	O
New	O
ovoid	O
opacity	O
developing	O
within	O
the	O
left	O
mid	O
lung	O
field,	O
which	O
may	O
represent	O
a	O
pseudotumor	O
from	O
fluid	O
tracking	O
within	O
the	O
fissure.	O
3)	O
Previously	O
noted	O
left	O
upper	O
lobe	O
nodule	O
persists,	O
but	O
less	O
well	O
distinct	O
on	O
the	O
current	O
exam.	O
CHEST	O
CT	O
with	O
contrast	O
___	O
1.	O
Left	O
upper	O
lobe	O
lung	O
nodule	O
shown	O
to	O
be	O
pulmonary	O
arteriovenous	O
malformation.	O
2.	O
Ovoid	O
opacity	O
demonstrated	O
to	O
be	O
pseudomass	O
from	O
pleural	O
fluid	O
in	O
the	O
major	O
fissure	O
with	O
a	O
small-to-moderate	O
left	O
and	O
trace	O
right	O
pleural	O
effusions.	O
3.	O
Patulous	O
fluid-filled	O
esophagus	O
with	O
fluid	O
in	O
the	O
esophagus	O
to	O
the	O
upper	O
and	O
cervical	O
esophagus	O
can	O
suggest	O
risk	O
of	O
aspiration	O
and	O
correlation	O
with	O
history	O
as	O
well	O
as	O
a	O
non-emergent	O
barium	O
study	O
can	O
be	O
obtained	O
if	O
deemed	O
clinically	O
appropriate.	O
4.	O
Extensive	O
collateralization	O
from	O
the	O
right	O
upper	O
extremity	O
deep	O
venous	O
system	O
suggesting	O
subclavian/axillary	O
venous	O
occlusion.	O
Subsequent	O
review	O
of	O
records	O
demonstrated	O
prior	O
right	O
axillary	O
and	O
subclavian	O
occlusion	O
shown	O
on	O
angiogram	O
during	O
___	O
line	O
placement,	O
___.	O
R	O
Upper	O
Extremity	O
U/s:	O
___	O
-	O
Limited	O
study	O
demonstrating	O
right	O
upper	O
extremity	O
venous	O
collaterals.	O
-	O
Subsequent	O
review	O
of	O
records	O
reveals	O
right	O
axillary/subclavian	O
chronic	O
occlusion	O
with	O
extensive	O
collaterals	O
demonstrated	O
on	O
angiogram	O
from	O
___	O
line	O
placement	O
on	O
___.	O
EKG:	O
NSR	O
with	O
STD>1mm	O
V4-5	O
which	O
are	O
old	O
and	O
likely	O
___	O
LVH.	O
FEMUR	O
___:	O
FINDINGS:	O
Projection	O
makes	O
direct	O
comparison	O
difficult;	O
however,	O
the	O
femoral	O
shaft	O
appears	O
foreshortened	O
compared	O
to	O
the	O
prior	O
study,	O
and	O
the	O
distal	O
femoral	O
margin	O
is	O
ill-defined.	O
There	O
is	O
soft	O
tissue	O
swelling.	O
The	O
findings	O
are	O
worrisome	O
for	O
osteomyelitis.	O
MICRO	O
DATA:	O
___	O
4:35	O
am	O
URINE	O
Source:	O
___.	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
MIXED	O
BACTERIAL	O
FLORA	O
(	O
>=	O
3	O
COLONY	O
TYPES),	O
CONSISTENT	O
WITH	O
SKIN	O
AND/OR	O
GENITAL	O
CONTAMINATION.	O
___	O
6:54	O
pm	O
EYE	O
Source:	O
Superficial.	O
**FINAL	O
REPORT	O
___	O
GRAM	O
STAIN	O
(Final	O
___:	O
NO	O
POLYMORPHONUCLEAR	O
LEUKOCYTES	O
SEEN.	O
NO	O
MICROORGANISMS	O
SEEN.	O
RESPIRATORY	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
11:51	O
am	O
PLEURAL	O
FLUID	O
GRAM	O
STAIN	O
(Final	O
___:	O
4+	O
(>10	O
per	O
1000X	O
FIELD):	O
POLYMORPHONUCLEAR	O
LEUKOCYTES.	O
NO	O
MICROORGANISMS	O
SEEN.	O
This	O
is	O
a	O
concentrated	O
smear	O
made	O
by	O
cytospin	O
method,	O
please	O
refer	O
to	O
hematology	O
for	O
a	O
quantitative	O
white	O
blood	O
cell	O
count..	O
FLUID	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
ANAEROBIC	O
CULTURE	O
(Preliminary):	O
NO	O
GROWTH.	O
ACID	O
FAST	O
SMEAR	O
(Final	O
___:	O
NO	O
ACID	O
FAST	O
BACILLI	O
SEEN	O
ON	O
DIRECT	O
SMEAR.	O
ACID	O
FAST	O
CULTURE	O
(Pending):	O
___	O
6:00	O
am	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
11:51	O
pm	O
STOOL	O
CONSISTENCY:	O
SOFT	O
**FINAL	O
REPORT	O
___	O
CLOSTRIDIUM	O
DIFFICILE	O
TOXIN	O
A	O
&	O
B	O
TEST	O
(Final	O
___:	O
Reported	O
to	O
and	O
read	O
back	O
by	O
N.	O
___	O
ON	O
___	O
AT	O
0525.	O
CLOSTRIDIUM	O
DIFFICILE.	O
FECES	O
POSITIVE	O
FOR	O
C.	O
DIFFICILE	O
TOXIN	O
BY	O
EIA.	O
(Reference	O
Range-Negative).	O
A	O
positive	O
result	O
in	O
a	O
recently	O
treated	O
patient	O
is	O
of	O
uncertain	O
significance	O
unless	O
the	O
patient	O
is	O
currently	O
symptomatic	O
(relapse).	O
___	O
3:26	O
pm	O
BLOOD	O
CULTURE	O
Source:	O
Venipuncture.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
12:40	O
pm	O
URINE	O
Site:	O
CATHETER	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
MIXED	O
BACTERIAL	O
FLORA	O
(	O
>=	O
3	O
COLONY	O
TYPES),	O
CONSISTENT	O
WITH	O
SKIN	O
AND/OR	O
GENITAL	O
CONTAMINATION.	O
___	O
11:25	O
am	O
BLOOD	O
CULTURE	O
#1.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
11:20	O
am	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
Brief	O
Hospital	O
Course:	O
On	O
admission,	O
the	O
patient	O
was	O
febrile	O
and	O
tachypneic	O
with	O
a	O
rising	O
lactate	O
on	O
admission.	O
Initial	O
concern	O
was	O
that	O
this	O
was	O
due	O
to	O
a	O
infected	O
loculated	O
effusion.	O
This	O
was	O
drained	O
by	O
interventional	O
radiology	O
on	O
___.	O
Gram	O
stain	O
was	O
negative	O
and	O
cultures	O
have	O
been	O
no	O
growth	O
from	O
this	O
effusion.	O
As	O
such,	O
it	O
appears	O
unlikely	O
that	O
the	O
effusion	O
was	O
the	O
cause	O
of	O
her	O
fevers/	O
SIRS.	O
Her	O
stool	O
was	O
positive	O
for	O
C.	O
Diff,	O
so	O
this	O
was	O
undoubtedly	O
contributing	O
to	O
her	O
septic	O
physiology.	O
Also	O
of	O
note,	O
she	O
was	O
noted	O
to	O
have	O
erythema	O
and	O
pain	O
around	O
her	O
right	O
stump	O
incision.	O
There	O
was	O
no	O
purulent	O
drainage.	O
This	O
may	O
have	O
been	O
the	O
source	O
of	O
her	O
fevers.	O
Infectious	O
disease	O
was	O
consulted	O
and	O
they	O
felt	O
that	O
the	O
most	O
likely	O
source	O
of	O
her	O
fevers/cause	O
of	O
her	O
presentation	O
was	O
the	O
right	O
stump	O
wound.	O
A	O
plain	O
xray	O
was	O
performed,	O
which	O
revealed	O
concerning	O
findings	O
for	O
osteomyelitis.	O
This	O
was	O
discussed	O
with	O
her	O
vascular	O
surgeon,	O
Dr.	O
___	O
feels	O
strongly	O
that	O
these	O
findings	O
are	O
post-operative	O
and	O
does	O
not	O
think	O
that	O
the	O
leg	O
is	O
infected.	O
The	O
decision	O
was	O
made	O
to	O
treat	O
empirically	O
with	O
two	O
weeks	O
of	O
vancomycin/zosyn.	O
Please	O
see	O
below	O
regarding	O
details.	O
#	O
Fevers/SIRS:	O
As	O
above,	O
the	O
most	O
likely	O
source	O
was	O
considered	O
to	O
be	O
her	O
stump	O
infection	O
--	O
cellulitis	O
versus	O
deep	O
soft	O
tissue	O
infection.	O
Of	O
note,	O
urine	O
and	O
blood	O
cultures	O
were	O
negative	O
throughout	O
her	O
admission.	O
She	O
has	O
been	O
afebrile	O
for	O
the	O
past	O
72	O
hours	O
with	O
only	O
___.	O
.	O
#	O
Complicated	O
Effusion:	O
This	O
was	O
drained	O
by	O
interventional	O
radiology.	O
As	O
above,	O
the	O
gram	O
stain	O
was	O
negative	O
and	O
cultures	O
have	O
been	O
no	O
growth.	O
AFB	O
stain	O
was	O
negative.	O
AFB	O
culture	O
is	O
pending	O
and	O
will	O
need	O
to	O
be	O
followed-up.	O
Cytology	O
was	O
negative.	O
It	O
is	O
not	O
clear	O
what	O
the	O
cause	O
of	O
her	O
effusion	O
was.	O
Of	O
note,	O
her	O
oxygenation	O
dramatically	O
improved	O
status/post	O
drainage	O
such	O
that	O
she	O
was	O
doing	O
well	O
on	O
room	O
air.	O
.	O
#	O
Right	O
stump	O
cellulitis	O
vs	O
deep	O
space	O
infection:	O
As	O
above,	O
infectious	O
disease	O
specialists	O
felt	O
strongly	O
that	O
she	O
has	O
a	O
deep	O
space	O
infection	O
but	O
vascular	O
surgery	O
disagreed.	O
She	O
was	O
treated	O
empirically	O
with	O
Vancomycin	O
and	O
Zosyn,	O
for	O
a	O
planned	O
two	O
week	O
course,	O
ending	O
___.	O
She	O
should	O
have	O
inflammatory	O
markers	O
monitored	O
(CRP	O
and	O
ESR)	O
as	O
well	O
as	O
CBC	O
and	O
basic	O
metabolic	O
panel	O
checked	O
weekly.	O
If	O
there	O
are	O
issues	O
and/or	O
if	O
her	O
ESR/CRP	O
increases,	O
this	O
should	O
be	O
reported	O
to	O
Dr.	O
___	O
in	O
the	O
infectious	O
disease	O
department	O
to	O
see	O
if	O
the	O
course	O
should	O
be	O
extended.	O
She	O
has	O
follow-up	O
scheduled	O
with	O
infectious	O
disease;	O
it	O
is	O
crucial	O
that	O
she	O
be	O
present	O
for	O
this	O
appointment.	O
.	O
#	O
Clostridial	O
difficile	O
infection:	O
The	O
patient	O
has	O
a	O
history	O
of	O
C.	O
Diff.	O
She	O
was	O
noted	O
to	O
have	O
diarrhea	O
on	O
admission	O
and	O
her	O
stool	O
was	O
positive	O
for	O
C.	O
Diff.	O
She	O
was	O
given	O
IV	O
flagyl	O
and	O
PO	O
vancomycin.	O
The	O
IV	O
flagyl	O
can	O
be	O
discontinued	O
on	O
discharge	O
per	O
infectious	O
disease.	O
She	O
should	O
continue	O
on	O
500	O
mg	O
vancomycin	O
PO	O
every	O
six	O
hours	O
through	O
___	O
-->	O
125	O
mg	O
vancomycin	O
PO	O
twice	O
daily	O
through	O
___	O
-->	O
125	O
mg	O
vancomycin	O
daily	O
through	O
___	O
-->	O
125	O
mg	O
vancomycin	O
PO	O
every	O
other	O
day	O
thorugh	O
___	O
-->	O
125	O
mg	O
vancomcyin	O
PO	O
every	O
third	O
day	O
for	O
five	O
doses.	O
.	O
#	O
Encephalopathy:	B-Delirium
likely	O
due	O
to	O
infection,	O
improved	O
during	O
hospital	O
stay.	O
She	O
was	O
A&Ox3	B-Delirium
at	O
the	O
time	O
of	O
discharge.	O
.	O
#	O
Anxiety:	O
Her	O
anxiety	O
was	O
severe	O
during	O
this	O
admission.	O
She	O
had	O
been	O
recently	O
changed	O
by	O
___	O
staff	O
from	O
paxil	O
to	O
duloxetine	O
and	O
she	O
felt	O
this	O
had	O
exacerbated	O
her	O
anxiety.	O
The	O
duloxetine	O
was	O
discontinued.	O
Psychiatry	O
was	O
consulted.	O
They	O
recommended	O
starting	O
remeron	O
7.5	O
mg	O
at	O
bedtime,	O
which	O
was	O
started	O
the	O
night	O
prior	O
to	O
discharge.	O
She	O
was	O
seen	O
by	O
social	O
work	O
who	O
felt	O
strongly	O
that	O
she	O
receive	O
further	O
counseling.	O
If	O
possible,	O
she	O
should	O
follow-up	O
with	O
a	O
psychiatrist	O
and	O
a	O
psychologist.	O
She	O
also	O
received	O
ativan	O
0.5	O
mg	O
as	O
needed	O
for	O
anxiety.	O
.	O
#	O
Essential	O
thrombocytosis:	O
Her	O
hydroxyurea	O
was	O
held	O
on	O
admission	O
given	O
acute	O
infection.	O
Her	O
platelets	O
increased	O
off	O
of	O
therapy	O
to	O
the	O
900's.	O
Hydroxyurea	O
was	O
restarted	O
two	O
days	O
prior	O
to	O
discharge.	O
She	O
should	O
have	O
her	O
platelet	O
count	O
rechecked	O
in	O
the	O
next	O
several	O
days.	O
If	O
her	O
counts	O
are	O
increasing,	O
hematology/oncology	O
should	O
be	O
consulted.	O
.	O
#	O
PVD	O
s/p	O
B	O
AKA	O
with	O
e/o	O
wound	O
infection	O
on	O
Rt:	O
See	O
above	O
re:	O
details	O
of	O
wound	O
infection.	O
She	O
will	O
need	O
to	O
follow-up	O
with	O
vascular	O
surgery;	O
appointment	O
scheduled.	O
.	O
#	O
H/O	O
PICC-ASSOCIATED	O
DVT:	O
Given	O
her	O
history	O
of	O
PICC-associated	O
DVT,	O
she	O
was	O
started	O
on	O
lovenox	O
at	O
treatment	O
doses.	O
.	O
#	O
AFIB:	O
Her	O
beta	O
blocker	O
was	O
held	O
on	O
admission	O
due	O
to	O
hypotension.	O
She	O
then	O
went	O
into	O
atrial	O
fibrillation	O
with	O
rapid	O
ventricular	O
response.	O
An	O
echo	O
had	O
been	O
recently	O
checked	O
without	O
evidence	O
of	O
structural	O
heart	O
disease.	O
TSH	O
was	O
checked	O
and	O
was	O
within	O
normal	O
limits.	O
She	O
was	O
started	O
on	O
a	O
beta	O
blocker	O
with	O
good	O
control	O
of	O
her	O
heart	O
rate.	O
She	O
should	O
continue	O
on	O
the	O
beta	O
blocker.	O
Regarding	O
anticoagulation,	O
she	O
is	O
receiving	O
lovenox,	O
once	O
her	O
surgical	O
issues	O
are	O
settled	O
a	O
discussion	O
should	O
be	O
had	O
regarding	O
whether	O
or	O
not	O
she	O
would	O
want	O
to	O
be	O
treated	O
with	O
coumadin.	O
.	O
#	O
PALLIATIVE	O
CARE:	O
Of	O
note,	O
Ms.	O
___	O
was	O
apparently	O
closely	O
followed	O
prior	O
to	O
her	O
amputation	O
by	O
palliative	O
care	O
service,	O
specifically	O
___.	O
___	O
saw	O
her	O
during	O
this	O
hospitalization	O
as	O
well	O
and	O
noted	O
that	O
prior	O
to	O
this	O
hospitalization	O
there	O
was	O
some	O
discussion	O
of	O
possibly	O
pursuing	O
a	O
more	O
palliative	O
approach,	O
including	O
perhaps	O
do	O
not	O
hospitalize	O
orders.	O
This	O
should	O
certainly	O
be	O
discussed	O
further	O
if	O
Ms	O
___	O
is	O
rehospitalized	O
in	O
the	O
near	O
future.	O
.	O
INACTIVE	O
ISSUES:	O
#	O
CAD	O
s/p	O
RCA	O
stent:	O
denying	O
any	O
CP,	O
cardiac	O
enzymes	O
were	O
flat.	O
-	O
continued	O
on	O
home	O
on	O
ASA	O
-	O
BB	O
as	O
above	O
.	O
#	O
Hypertension:	O
continued	O
on	O
beta	O
blocker	O
as	O
above.	O
.	O
#	O
Rheumatoid	O
arthritis:	O
cont	O
home	O
azathioprine	O
50mg	O
daily	O
&	O
prednisone	O
5mg	O
daily.	O
.	O
#	O
Hypothyroidism:	O
Continue	O
home	O
levothyroxine	O
.	O
CODE	O
STATUS:	O
DNR	O
but	O
okay	O
to	O
intubate	O
.	O
TRANSITIONAL	O
ISSUES	O
-	O
check	O
weekly	O
CBC/basic	O
metabolic/ESR/CRP	O
-	O
consider	O
psychiatry	O
referral	O
-	O
consider	O
starting	O
coumadin	O
for	O
AFib	O
anticoagulation	O
-	O
anxiety	O
treatment	O
and/or	O
psychiatry	O
referral	O
-	O
f/u	O
final	O
cultures	O
of	O
thoracentesis	O
Medications	O
on	O
Admission:	O
MVI	O
ASA	O
81mg	O
qd	O
Atenolol	O
50mg	O
qd	O
Vancomycin	O
125mg	O
po	O
q6h	O
-	O
last	O
dose	O
___	O
Vitamin	O
D	O
Paroextine	O
20mg	O
qd	O
-	O
plan	O
for	O
weaning	O
Cymbalta	O
30mg	O
qd	O
Gabapentin	O
400mg	O
qhs	O
and	O
300mg	O
tid	O
Prednisone	O
5mg	O
qd	O
Hydroyurea	O
500mg	O
bid	O
Azathioprine	O
50mg	O
qd	O
Omeprazole	O
20mg	O
qd	O
Dilaudid	O
___	O
po	O
q4h	O
prn	O
pain	O
Folic	O
acid	O
Levothyroxine	O
100mg	O
qd	O
Phenergan	O
12.5mg	O
po/pr	O
q6h	O
prn	O
nausea	O
Ativan	O
0.5mg	O
po	O
q8h	O
prn	O
anxiety	O
Discharge	O
Medications:	O
1.	O
acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
pain,	O
fever.	O
2.	O
multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
cholecalciferol	O
(vitamin	O
D3)	O
400	O
unit	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
gabapentin	O
400	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
HS	O
(at	O
bedtime).	O
5.	O
prednisone	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
gabapentin	O
300	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
7.	O
azathioprine	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
8.	O
omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
DAILY	O
(Daily).	O
9.	O
levothyroxine	O
100	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
10.	O
folic	O
acid	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
11.	O
ipratropium	O
bromide	O
0.02	O
%	O
Solution	O
Sig:	O
One	O
(1)	O
nebulizer	O
Inhalation	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
wheezing.	O
12.	O
erythromycin	O
5	O
mg/gram	O
(0.5	O
%)	O
Ointment	O
Sig:	O
0.5	O
ointment	O
Ophthalmic	O
QID	O
(4	O
times	O
a	O
day)	O
for	O
2	O
days.	O
13.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
14.	O
Toprol	O
XL	O
100	O
mg	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
PO	O
once	O
a	O
day:	O
hold	O
for	O
sbp<90,	O
hr<55.	O
15.	O
lorazepam	O
0.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q8H	O
(every	O
8	O
hours)	O
as	O
needed	O
for	O
anxiety	O
:	O
hold	O
sbp<90,	O
sedated,	O
rr<12.	O
16.	O
cyproheptadine	O
4	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q8H	O
(every	O
8	O
hours).	O
17.	O
vancomycin	O
in	O
D5W	O
1	O
gram/200	O
mL	O
Piggyback	O
Sig:	O
One	O
(1)	O
gram	O
Intravenous	O
Q	O
12H	O
(Every	O
12	O
Hours):	O
through	O
___.	O
18.	O
Zosyn	O
4.5	O
gram	O
Recon	O
Soln	O
Sig:	O
4.5	O
grams	O
Intravenous	O
every	O
eight	O
(8)	O
hours:	O
through	O
___.	O
19.	O
vancomycin	O
250	O
mg	O
Capsule	O
Sig:	O
Two	O
(2)	O
Capsule	O
PO	O
Q6H	O
(every	O
6	O
hours):	O
take	O
500	O
mg	O
every	O
six	O
hours	O
through	O
___	O
then	O
take	O
125	O
mg	O
daily	O
through	O
___	O
then	O
take	O
125	O
mg	O
every	O
other	O
day	O
through	O
___	O
then	O
take	O
125	O
mg	O
every	O
third	O
day	O
for	O
five	O
doses.	O
20.	O
hydroxyurea	O
500	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
21.	O
mirtazapine	O
15	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
22.	O
enoxaparin	O
60	O
mg/0.6	O
mL	O
Syringe	O
Sig:	O
Fifty	O
(50)	O
mg	O
Subcutaneous	O
Q12H	O
(every	O
12	O
hours):	O
continue	O
until	O
___	O
line	O
pulled.	O
23.	O
nystatin	O
100,000	O
unit/mL	O
Suspension	O
Sig:	O
Five	O
(5)	O
ML	O
PO	O
QID	O
(4	O
times	O
a	O
day).	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Right	O
stump	O
wound	O
infection	O
C.	O
Diff	O
colitis	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	O
chair	O
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
with	O
fevers,	O
confusion	B-Delirium
and	O
concern	O
for	O
infected	O
fluid	O
around	O
the	O
lung.	B-Lower_respiratory_tract_infection
You	O
were	O
taken	O
for	O
CT	O
guided	O
aspiration,	O
but	O
the	O
fluid	O
was	O
negative	O
for	O
infection.	B-Lower_respiratory_tract_infection
You	O
were	O
also	O
noted	O
to	O
have	O
pain	O
and	O
redness	O
around	O
your	O
right	O
stump	O
wound.	O
This	O
improved	O
with	O
treatment.	O
You	O
were	O
also	O
noted	O
to	O
have	O
diarrhea	O
due	O
to	O
c.	O
diff,	O
which	O
improved	O
with	O
therapy.	O
You	O
will	O
need	O
to	O
continue	O
on	O
this	O
therapy	O
for	O
a	O
few	O
weeks.	O
A	O
PICC	O
line	O
was	O
placed	O
for	O
you	O
to	O
get	O
your	O
antibiotics.	O
Given	O
your	O
history	O
of	O
forming	O
clots,	O
you	O
were	O
started	O
on	O
lovenox.	O
Followup	O
Instructions:	O
___	O

